Status:
COMPLETED
Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
Lead Sponsor:
Charles Drew University of Medicine and Science
Conditions:
Diabetes
Depression
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
This proposed study will test the following hypothesis: Treating depression in Hispanics and African Americans with diabetes will improve their HbA1c and quality of life while on intervention and six ...
Detailed Description
The medication to be used will be sertraline (Zoloft). Sertraline (Zoloft)has been proven in clinical trials to be an effective and well tolerated prescription medication that improves the quality and...
Eligibility Criteria
Inclusion
- All patients (men, women) who are African American or Hispanic over the age of 21 who have been diagnosed with type 2 diabetes and have a HbA1c of greater than 8.0%. Subjects with neuropathic pain will be included in the study. Their pain will be assessed via a validated pain scale. Their primary care providers will treat their pain as necessary.
Exclusion
- Pregnant women, patients on dialysis, patients with liver disease or liver enzymes elevated three times above normal, patients with blood pressure greater than 160 systolic or 95 diastolic on two consecutive visits, patients with history of severe depression (as determined by hospitalization or the HAM-D survey) or suicide attempts, patients on therapy for depression, patients already taking SSRI's, and patients with psychotic features or bipolar disease.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00624013
Start Date
September 1 2006
End Date
October 1 2008
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles Drew University
Los Angeles, California, United States, 90059